In a workshop held in Giens in September 1994, representatives of drug companies and scientists met to discuss the place of women in clinical trials. They recommend that, in phase II and III studies, men and women should be included in a proportion equivalent to that observed for the condition studied. They also recommend that the impact of the gender on the results should be systematically studied.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[women clinical
4
clinical trials]
4
trials] workshop
4
workshop held
4
held giens
4
giens september
4
september 1994
4
1994 representatives
4
representatives drug
4
drug companies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!